Delving into the Latest Updates on Shanghai Yahong Medical Technology Co., Ltd. with Synapse

Overview

Tags

Neoplasms

Other Diseases

Urogenital Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Neoplasms	1

Top 5 Drug Type	Count

Small molecule drug	1

Helps HSIL patients with histopathological diagnosis and adequate colposcopy to preserve the matrix of supporting cells, thereby preserving the function of the cervix and avoiding the side effects associated with surgery. Prove the effectiveness and safety of the product. Compared with existing treatments, Cevira? Therapy has obvious potential advantages.

Start Date20 Oct 2020

Sponsor / Collaborator

Bioglan AB /Drug Delivery Business/

[+2]

100 Clinical Results associated with Shanghai Yahong Medical Technology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Shanghai Yahong Medical Technology Co., Ltd.

Login to view more data

100 Deals associated with Shanghai Yahong Medical Technology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Shanghai Yahong Medical Technology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

IND Approval

1

Phase 3 Clinical

Login to view more data